Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytochrome P450 expression (CYP) in non-small cell lung cancer.

Frontiers in bioscience : a journal and virtual library - 1 Jan 2007

Oyama Tsunehiro, Sugio Kenji, Uramoto Hidetaka, Kawamoto Toshihiro, Kagawa Norio, Nadaf Sorena, Carbone David, Yasumoto Kosei

Abstract excerpt

The cytochrome P450 (CYP) is associated with tumor development and progression as well as activation of anti-cancer prodrugs and their metabolic clearance. In this study, we investigated the expression of aryl-hydrocarbon receptor (AH-R) and four CYPs (CYP1A1, CYP2A6, CYP2E1 and CYP3A) as putative diagnostic markers in 78 non-small cell lung cancers (NSCLC) along with clinical features of the patients. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Carcinoma, Squamous Cell

Share to Cytochrome P-450 CYP1A1

Share to Cytochrome P-450 CYP2E1

Share to Cytochrome P-450 Enzyme System

Share to Receptors, Aryl Hydrocarbon

Source

Identifiers

PMID: 17127240
DOI: 10.2741/2232

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytochrome P450 expression (CYP) in non-small cell lung cancer.PMID 17127240Read ↗

Increased cytochrome P450 and aryl hydrocarbon receptor in bronchial epithelium of heavy smokers with non-small cell lung carcinoma carries a poor prognosis.Semantic proximity Read ↗

CYP4B1 is a prognostic biomarker and potential therapeutic target in lung adenocarcinomaSemantic proximity Read ↗

Cytochrome P450 expression in oesophageal cancer.Semantic proximity Read ↗

Pulmonary CYP2A13 levels are associated with early occurrence of lung cancer-Its implication in mutagenesis of non-small cell lung carcinoma.Semantic proximity Read ↗

Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene PolymorphismsSemantic proximity Read ↗

Polymorphism of cytochrome p450, glutathione-s-transferase and N-acetyltransferases: influence on lung cancer susceptibility.Semantic proximity Read ↗

CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathwaySemantic proximity Read ↗

Cytochromes P450 and cancer.Semantic proximity Read ↗

Expression of aromatase CYP19 and its relationship with parameters in NSCLC.Semantic proximity Read ↗

Decreased Aryl Hydrocarbon Receptor Gene Expression and Polymorphic Variants Association with Increase COPD Risk.Semantic proximity Read ↗

Cytochrome P450 4B1 (CYP4B1) as a target in cancer treatmentSemantic proximity Read ↗

Xenobiotic metabolism in differentiated human bronchial epithelial cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.